Category

Lions Research Foundation Recognizes a Lifetime of Dedication August, 2014 | Written by: Havener Eye Institute | Ohio State University Born in Germany in 1940 at the beginning of WWII, Norbert was no stranger to deprivation and suffering. It was harsh growing up in a combat zone.

Welcome to the Ohio Lions Eye Research Foundation’s web site. In these pages you will find interesting and useful information regarding conditions affecting sight, and the efforts of the Ohio Lions to prevent blindness through research. Our foundation was established over 60

At a recent meeting of the Ohio Lions Eye Research Foundation Board of Trustees, the trustees approved the distribution of $128,400 in eye research, diabetes research, age-related macular degeneration and fellowship grants. OLERF would like thank all the Ohio Lions clubs and

Lion Larry Leguire Ph.D., MBA has retired as Scientific Advisor of the Ohio LIONS Eye Research Foundation (OLERF) effective Dec. 1, 2011.  Dr. Leguire served as Scientific Advisor of the OLERF since 1996.  In the year 2000, he established and served as the Web Master of the

UNIVERSITY of CINCINNATI DEPARTMENT OF OPHTHALMOLOGY by: Winston  Kao, Ph.D. PROGRESS REPORT Significance Corneal transplantation, i.e., penetrating and lamellar keratoplasty, is the most effective treatment of corneal blindness caused by congenital gene mutation and trauma.

Investigator: Andrew Hartwick, OD PhD; College of Optometry, Ohio State University Introduction: There is now considerable evidence that three types of photoreceptors (rods, cones and intrinsically photosensitive retinal ganglion cells [ipRGCs]) contribute photic information to

CASE WESTERN RESERVE UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY AND VISUAL SCIENCES OHIO LIONS EYE RESEARCH FOUNDATION Continuation Grant Application, 2011 Jonathan H. Lass, M.D., Charles I Thomas Professor and Chairman Eric Pearlman, Ph.D., Professor and Director of Research

Intravitreal anti-VEGF agents such as avastin, lucentis and macugen with wet macular degeneration.  (Christoforidis) The project of radiolabeling of anti-VEGF agents was actively continued these past 12 months. The results of the work have received national and international

NATIONWIDE CHILDREN’S HOSPITAL DEPARTMENT OF OPHTHALMOLOGY PROGRESS REPORT In 2010-2011 research efforts continued to concentrate on identifying sites within the brain responsible for the abnormal eye movements in patients with infantile nystagmus syndrome. Dr. Kashou in